PDT Partners’s Covetrus, Inc. Common Stock CVET Stock Holding History

PDT Partners’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-12,525	Closed	-$338K	–	963
2021 Q2	$338K	Buy	+12,525	New	+$350K	0.02%	601

Other funds holding CVET

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return

FCM

Freshford Capital Management Rye Brook, New York $200M AUM 31.49% 1-Year Est. Return

PDT Partners's CVET Position: Q3 2021 in Review

PDT Partners sold out of Covetrus, Inc. Common Stock (CVET) in Q3 2021, closing a stake of 12,525 shares — an estimated $338K sold.

PDT Partners first reported a position in CVET in Q2 2021 and held it in 1 quarter. The position peaked at $338K in Q2 2021. 260 funds tracked by Wall St. Rank hold CVET as of Q3 2021.

PDT Partners reported no remaining Covetrus, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
PDT Partners sold 12,525 Covetrus, Inc. Common Stock shares in Q3 2021, an estimated $338K.
PDT Partners first reported a position in Covetrus, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
PDT Partners's Covetrus, Inc. Common Stock position peaked at $338K in Q2 2021.
260 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q3 2021.

Based on PDT Partners's 13F filing for Q3 2021, filed 15 Nov 2021.